Remimazolam is a newly approved benzodiazepine characterized by rapid onset, predictable maintenance, fast recovery, and availability of a reversal agent. We describe four cases of patients who received monitored anesthesia care with remimazolam for gynecological day surgery.
Keywords: ambulatory surgery; outpatient procedures; sedation; ultra‐short acting benzodiazepine.
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.